Jungwirth J

Department of Adult Psychiatry and Psychotherapy, University Hospital of Psychiatry Zurich, University of Zurich, Switzerland.

2 preprints · 4 papers · ORCID

PreprintKetamine

Esketamine for treatment-resistant depression: Comparing two maintenance schedules in an observational real-world study

Westenhöfer S, Ehrt Y, Provaznikova B +9

Europe PMC2026
ArticlePsilocybin

Real-World Psilocybin Therapy for Treatment-Resistant Depression: A Retrospective Observational Study.

Jungwirth J, Westenhöfer S, Aicher HD +5

Europe PMC2026
PreprintPsilocybin

Real-World Psilocybin Therapy for Treatment-Resistant Depression: a Retrospective Observational Study

Jungwirth J, Westenhöfer S, Aicher H +5

Europe PMC2025
ArticlePsilocybin

Psilocybin increases emotional empathy in patients with major depression.

Jungwirth J, von Rotz R, Dziobek I +2

Europe PMC2025
ArticlePsilocybin

[Psychedelic and dissociative agents in psychiatry: challenges in the treatment].

Jungwirth J, Bavato F, Quednow BB

Europe PMC2024
ArticlePsilocybin

Single-dose psilocybin-assisted therapy in major depressive disorder: A placebo-controlled, double-blind, randomised clinical trial.

von Rotz R, Schindowski EM, Jungwirth J +9

Europe PMC2023